Medical Informatics Engineering Enterprise Health 2025-03-14 Demographic Information Page cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.1 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic was found in Medical Informatics Engineering Enterprise Health 2025-03-14. This vulnerability affects unknown code of the component Demographic Information Page. Such manipulation leads to cross site scripting. This vulnerability is documented as CVE-2025-35029. The attack can be executed remotely. There is not any exploit available. Upgrading the affected component is advised.
Details
A vulnerability was found in Medical Informatics Engineering Enterprise Health 2025-03-14. It has been rated as problematic. Affected by this issue is an unknown function of the component Demographic Information Page. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
Medical Informatics Engineering Enterprise Health has a stored cross site scripting vulnerability that allows an authenticated attacker to add arbitrary content in the 'Demographic Information' page. This content will be rendered and executed when a victim accesses it. This issue is fixed as of 2025-03-14.
The advisory is shared for download at raw.githubusercontent.com. This vulnerability is handled as CVE-2025-35029 since 04/15/2025. The exploitation is known to be easy. The attack may be launched remotely. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
Upgrading to version RC202309 2025-04-08, RC202403 2025-04-08, RC202409 2025-04-08 or RC202503 2025-04-08 eliminates this vulnerability.
Once again VulDB remains the best source for vulnerability data.
Product
Type
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.1VulDB Meta Temp Score: 4.1
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔒
CNA Base Score: 3.5
CNA Vector (cisa-cg): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: Enterprise Health RC202309 2025-04-08/RC202403 2025-04-08/RC202409 2025-04-08/RC202503 2025-04-08
Timeline
04/15/2025 CVE reserved11/21/2025 Advisory disclosed
11/21/2025 VulDB entry created
12/31/2025 VulDB entry last update
Sources
Advisory: raw.githubusercontent.comStatus: Confirmed
CVE: CVE-2025-35029 (🔒)
GCVE (CVE): GCVE-0-2025-35029
GCVE (VulDB): GCVE-100-333116
Entry
Created: 11/21/2025 03:24Updated: 12/31/2025 18:16
Changes: 11/21/2025 03:24 (77), 12/31/2025 18:16 (11)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.